Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Fluorescein Angiography Findings in Stage 3 Retinopathy of Prematurity in Zone II Treated With or Without Anti-VEGF
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Volume -, Issue -, Pages 112067212210766
Publisher
SAGE Publications
Online
2022-02-22
DOI
10.1177/11206721221076691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression
- (2019) Aslı Vural et al. INTERNATIONAL OPHTHALMOLOGY
- The heterozygous EDNRB mutation in a Chinese family with Waardenburg syndrome type I
- (2019) Huan-Huan Cheng International Journal of Ophthalmology
- Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings
- (2018) Domenico Lepore et al. OPHTHALMOLOGY
- Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography
- (2018) Aslı Vural et al. INTERNATIONAL OPHTHALMOLOGY
- PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY
- (2017) Jose M. Garcia Gonzalez et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY
- (2017) Birgit Lorenz et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?
- (2016) Maram Isaac et al. OPHTHALMOLOGY
- REACTIVATION OF RETINOPATHY OF PREMATURITY AFTER RANIBIZUMAB TREATMENT
- (2015) Ryan K. Wong et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity
- (2014) Sjakon G Tahija et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Fluorescein angiography to estimate normal peripheral retinal nonperfusion in children
- (2012) Michael P. Blair et al. JOURNAL OF AAPOS
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
- (2011) Helen A. Mintz-Hittner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity
- (2010) Domenico Lepore et al. OPHTHALMOLOGY
- Intravitreous Bevacizumab as Anti–Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity: A Morphologic Study
- (2008) Lingkun Kong ARCHIVES OF OPHTHALMOLOGY
- INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II
- (2008) HELEN A. MINTZ-HITTNER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started